Missed periods lasting three or more months, heavy bleeding, or intermenstrual spotting should prompt a GP review, and pregnancy should always be excluded
Standard community protocols run tirzepatide alone for the first 8 weeks (2.5 5 mg/week) to confirm GI tolerance, then add cagrilintide at 0.25 mg/week starting Week 9
GIP supports metabolic function through a complementary pathway
PlexusDx helps you understand whether this symptom reflects your individual peptide biology or requires dose adjustment
Gastroenterology 152 , 19982010 (2017)
These medications include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, approved only for diabetes), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity), which is a dual GLP-1/GIP receptor agonist